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ABSTRACT The clinico-epidemiological features of diseases
caused by group A streptococci (GAS) is presented through
the lens of the ecology, population genetics, and evolution of
the organism. The serological targets of three typing schemes
(M, T, SOF) are themselves GAS cell surface proteins that have a
myriad of virulence functions and a diverse array of structural
forms. Horizontal gene transfer expands the GAS antigenic cell
surface repertoire by generating numerous combinations of M,
T, and SOF antigens. However, horizontal gene transfer of the
serotype determinant genes is not unconstrained, and therein
lies a genetic organization that may signify adaptations to a
narrow ecological niche, such as the primary tissue reservoirs of
the human host. Adaptations may be further shaped by selection
pressures such as herd immunity. Understanding the molecular
evolution of GAS on multiple levels—short, intermediate, and
long term—sheds insight on mechanisms of host-pathogen
interactions, the emergence and spread of new clones,
rational vaccine design, and public health interventions.

ECOLOGY: HOST TISSUES AND DISEASES
The group A streptococcus (GAS; Streptococcus pyogenes) is a free-living organism. Its ecological niche appears to be quite narrow, and its only known biological
host of import is humans. There may be occasional or
very rare natural infections in non-human primates and
other mammals (1, 2).
The primary sites for GAS colonization of the human
host involve two tissues: the oropharyngeal mucosal
epithelium of the upper respiratory tract (URT) and the
superﬁcial layers of the epidermis. GAS have no known
environmental reservoir of signiﬁcance, and transmis-

sion is almost exclusively person to person, via either
respiratory droplets or direct contact. Thus, the throat
and skin of the human host are the primary habitats for
GAS. It is at these two tissue sites that GAS undergo
successful reproductive growth and transmission of
progeny to new hosts (Fig. 1).
Streptococcal pharyngitis and impetigo are superﬁcial, self-limiting infections that usually cause a mild illness that resolves within 2 weeks, even if left untreated.
Both are primarily diseases of childhood. Once colonization is established at the URT, the organism can cause
a symptomatic pharyngitis, with or without tonsillitis.
Symptomatic infection caused by GAS is typically characterized by a copious purulent exudate. Oropharyngeal
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FIGURE 1 Transmission routes for GAS. From the throat, GAS can transmit via the respiratory route to a new host, where it either causes pharyngitis or persists in a quiescent
carrier state. In a carrier state, the organism is presumed to be only weakly transmissible.
Transmission from the throat to skin is relatively rare. From an impetiginous skin lesion, the
organism can be transmitted by direct contact to the slightly damaged skin of a new host
or to other damaged skin sites on the same host, causing multiple skin lesions. GAS can
also be transmitted from a skin lesion to the throat of the same host, but it is widely
assumed to enter a carrier state and is only weakly transmissible. From either the throat
or skin, the organism can invade normally sterile deeper tissue, but this is rare relative to
superﬁcial infections.

infection can be cleared via a protective antibody that is
produced by the host in response to infection. Alternatively, a “clinically inapparent” infection can arise wherein
the infected individual lacks obvious clinical symptoms
of illness, yet a speciﬁc immune response is mounted and
directed to antigens of the infecting organism (3).
Another type of GAS-human interaction that can
occur at the URT is asymptomatic carriage, where a
vigorous host immune response to many/most GAS
antigens is lacking (4). The carrier state can persist for
weeks or months, and the organism (presumably) remains capable of transmission to a new host. However,
relative to acute pharyngitis, the number of organisms
present during carriage may be vastly reduced, and GAS
are often in an altered dormant-like state signiﬁed by a
relative lack of M protein expressed on the cell surface.
Intracellular invasion of epithelial cells by GAS may
contribute to persistent infection (5). Microcolony and

bioﬁlm formation, and the bacterial communities that
arise, may also be a key part of the ecology of the GAS
carrier state (6).
At the skin, GAS survive and replicate below the dry
corniﬁed layer, provoking a strong inﬂammatory response that gives rise to the purulent lesions of nonbullous impetigo, a form of pyoderma. Recovery of GAS
from normal skin can precede impetigo by ∼10 days (7,
8). However, it is not entirely clear whether there exists
stable GAS colonization and/or a true long-term carrier
state at the skin; uncertainty stems from the duration of
GAS association with normal human skin in the absence
of inﬂammation (i.e., disease), which may be transient
(9). Breaks in the stratum corneum, which can be quite
minor and barely noticeable, are a requirement for GAS
to establish a ﬁrm foothold at this tissue site and cause
disease. The scabies mite infests the epidermal layer just
below the stratum corneum; scabies can cause intense
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itching and is a key risk factor in the development of
GAS impetigo in many tropical communities (10–12).
Also, it is not uncommon for Staphylococcus aureus to
be a copathogen along with GAS in impetiginous skin
lesions (13, 14). At least some strains of GAS that cause
impetigo can subsequently spread from skin lesions to
colonize the URT, peaking at 2 to 3 weeks post-skin
infection (7, 8) (Fig. 1).
The relative incidence of GAS disease varies throughout the world in accordance with both season and locale.
In the temperate regions of North America and Europe,
pharyngitis is highly prevalent during the cold winter
months, whereas impetigo thrives during warm, humid
weather and is far less prevalent. In many tropical regions, such as the Northern Territory of Australia, GAS
impetigo is far more common than pharyngeal infection among the indigenous population, and there are no
discrete seasonal peaks in the incidence of disease (10).
Climate and the level of hygiene strongly inﬂuence the
prevalence of impetigo, whereas indoor crowding is a
major risk factor for URT infection. These risk factors
largely reﬂect the primary modes of transmission.
Worldwide there are an estimated >616 million
cases of GAS pharyngitis per year (15), and >162 million
cases of impetigo at any given time (16). In a study
conducted ∼40 years ago in the United States, for children between the ages of 5 and 7 years, it was estimated
that an average of half experience one GAS infection
annually (17). During the peak season, asymptomatic
carriage rates at the URT range from (very) roughly 15
to 20% or higher; this value depends on the exact cohort (18). Bacteria tend to attain high numbers and densities during purulent infection. Large bacterial counts
yield large infective doses, which in turn can lead to
the exposure of several susceptible hosts with the minimum infective dose, thereby augmenting transmission
and spread.
A primary reason why GAS is a major public health
problem is because of its ability to cause invasive
(iGAS) disease and trigger nonsuppurative (i.e., nonpus-forming) sequelae. The latter diseases are of an autoimmune (acute rheumatic fever [ARF]) or immune
complex (acute glomerulonephritis) nature. Collectively,
the severe GAS diseases are responsible for >500,000
deaths each year (15).
In iGAS disease, bacteria gain access to deep tissue
that is normally sterile. Consistent with pharyngitis providing the major GAS reservoir in temperate regions,
iGAS disease is also more prevalent in these regions
during the winter months (19). Intracellular invasion or
paracellular transport of GAS at the URT may facilitate

its access to the bloodstream. iGAS infection can be
particularly severe in cases of necrotizing fasciitis and
toxic shock syndrome. Although iGAS disease is associated with elevated rates of morbidity and mortality, its
frequency of occurrence is relatively low. Populationbased surveys of iGAS disease over the past 2 decades
estimate the annual incidence at ∼3 to 4 per 100,000
people per year in the United States and Europe, although more recently, the incidence of iGAS disease
in the United States has increased to ∼5 per 100,000
people per year (20); worldwide, there are an estimated
663,000 new iGAS cases per year (15). Thus, the overall
incidence of iGAS disease is ∼1,000-fold lower than
the incidence of new pharyngitis and impetigo infections. Invasion of normally sterile tissue is often a result of “bacteremia without focus.” When a lack of
evidence for a superﬁcial infection is coupled to GAS
growth being largely restricted to deep tissue, and the
patient is sequestered and nonambulatory, iGAS disease becomes a transmission dead end for the infecting
bacterium.
From the ecological perspective of long-term evolution, GAS ﬁtness is largely shaped by adaptations to its
primary tissue reservoirs; acquisition of traits that enhance ﬁtness in iGAS disease is probably coincidental.
In North America, the composition of the iGAS strain
population largely overlaps with the population of GAS
strains recovered from superﬁcial (pharyngitis) infections (21), although a few strains appear to have invasive
indices at the more extreme high or low ends (22).
Cutaneous wound infections can be considered a
mild form of iGAS disease, wherein the histopathology
is distinct from nonbullous impetigo. Depending on the
study, wound infections are occasionally classiﬁed under
the broader umbrellas of “pyoderma” or “skin lesions.”
Ecthyma is a severe form of impetigo with extensive
dermis involvement. Impetigo largely afﬂicts younger
children and is mostly prevalent in communities with
a warm humid climate (tropics, summer), whereas in
contrast, GAS wound infections occur in all age groups
and in all geographic regions, including those where
URT disease predominates.
Transmission of GAS leading to cutaneous wound
infections can occur from one tissue to another site within
an individual (e.g., URT → broken skin), through shared
skin-penetrating devices (e.g., needles), and possibly by
direct person-to-person contact via open wounds. Skin
contact may be an important mode of transmission in a
recent GAS outbreak among adults that include intravenous drug users (IVDUs) and homeless people in a
temperate zone (23, 24).

ASMscience.org/MicrobiolSpectrum

3
Downloaded from www.asmscience.org by
IP: 64.118.223.196
On: Wed, 07 Nov 2018 01:48:52

Bessen et al.

ECOLOGY: TRANSMISSION
The superﬁcial nature of pharyngitis and impetigo provides GAS with an easy exit from infected hosts and an
easy entrance into new hosts. Transmission is strongly
inﬂuenced by the GAS agent and human host, coupled
with both microenvironmental and macroenvironmental factors. The dynamics of both the GAS and human
host populations largely dictate the scope of GAS disease
outbreaks and epidemics.

Macroenvironment Risk Factors
As discussed above (“Ecology: Host Tissues and Diseases”), the primary environmental risk factors for GAS
pharyngitis and impetigo are cold winters and tropical
conditions, respectively. Copathogens that may elevate
the risk for GAS infection include the scabies mite and
S. aureus for impetigo and, possibly, undeﬁned infectious agents for pharyngitis.

GAS-Microenvironment Factors
The microenvironments at the throat and skin differ
from one another in numerous ways. Also, each tissue
undergoes ﬂuctuations in local conditions as a GAS infection evolves. To initiate infection, the GAS organism
needs to be reasonably well adapted to the local tissue
microenvironment. Distinctions between classic throat
and skin strains of GAS (see “Epidemiology: Global
Trends” below) are probably rooted, at least in part, in
host tissue-speciﬁc adaptations. GAS cell surface components implicated in transmission and/or mediating
colonization in a new host include the hyaluronic acid
capsule and pili, among numerous other extracellular
proteins (25–29). Yet the recent emergence and successful spread of emm89 iGAS strains is coupled to
a loss in capsule (30, 31) (see “Epidemiology: Building
Evolutionary Models” below). Conceivably, GAS transmission factors are strain speciﬁc.
At the URT, GAS initially encounter saliva and mucus
secretions that contain mucins, secretory IgA, digestive
enzymes, and antimicrobial peptides. At the broken
surface just below the corniﬁed layer of the skin, GAS
face the early stages of wound healing: an inﬂammatory
response in the epidermis is characterized by inﬁltration of low numbers of polymorphonuclear leukocytes
and small amounts of plasma containing Igs and complement, plus antimicrobial peptides. As the infection
evolves, the bacteria deploy virulence factors that are
able to thwart host defenses, allowing GAS to undergo
a net increase in growth, with a concomitant increase in
inﬁltration by inﬂammatory cells leading to the accumulation of a purulent exudate (32).

Competition with normal ﬂora is a key determinant
of GAS colonization at the URT. In general terms, competition can be stiffest between highly related organisms.
The closest genetic relative of GAS/S. pyogenes that is
also a common human URT colonizer is Streptococcus
dysgalactiae subspecies equisimilis (SDSE). SDSE usually
have cell wall-associated group C or G group carbohydrate and are largely restricted to humans, with >60%
genome sequence homology to S. pyogenes (33, 34). A
few uncommon lineages of SDSE have group A (CHO-A)
or group L carbohydrate (thus, the term “GAS” is largely
equivalent to “S. pyogenes,” and in this report, the two
terms are completely equivalent unless otherwise noted).
Recently, a widely disseminated and longstanding iGAS
lineage of SDSE was described that appears to have
arisen from a recombination event involving CHO-A
biosynthesis genes from S. pyogenes (35).
SDSE bacteria are largely commensals of the oropharynx but are capable of causing many of the diseases attributed to S. pyogenes (36, 37). Like its close
cousin, SDSE expresses capsules composed of hyaluronic acid, cell surface proteins that include M protein
and T-antigens, and exotoxins such as streptolysin O;
however, SDSE lacks some critical S. pyogenes virulence
factors, such as the secreted cysteine proteinase SpeB.
Besides the potential sharing of human host receptors for adherence to the epithelium, relatively little is
known about how these two species—GAS and SDSE—
compete for nutrients and other critical resources (38).
Signaling between GAS, SDSE, and other streptococcal
species has been demonstrated (39), and GAS are susceptible to killing by bacteriocins produced by other
streptococcal species (40). Much remains to be uncovered regarding the role of the microbiome in shaping the
success of GAS in colonizing and/or causing infection at
the URT.
GAS physiology is heavily inﬂuenced by the nature
and concentration of carbon sources (e.g., glucose),
oxygen, and its toxic byproducts, among numerous
other factors present in different tissues under shifting
conditions (41, 42). Changes in the local microenvironment, coupled with increased bacterial density and
nutrient depletion as the organisms reproduce and yield
new progeny, impact the transcriptional program of the
GAS cell, which in turn directs activation or repression
of numerous genes associated with pathogenesis, and
presumably transmissibility as well (43).
Acquisition of GAS at the URT does not necessarily
lead to an infection, and in the asymptomatic carrier
state, the local microenvironment is substantially different from the purulent environs. In the carrier state,
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virulence factor gene expression and the requirements
for adaptation appear to be quite different (e.g., 44, 45).

Human (Host) Factors
In general terms, successful transmission of a pathogen
depends on the availability of susceptible hosts, as well
as the ratio of susceptible to resistant hosts in the context of the number of person contacts and potential exposures (46). Host genetic susceptibility (or resistance)
to superﬁcial GAS infections has not been characterized,
and evidence for its existence is largely lacking.
Highly efﬁcacious immunological protection against
GAS infection is strain speciﬁc (i.e., M type-speciﬁc)
(47), although a host immune response directed toward
numerous other antigenic targets can confer at least
partial protection (48, 49). Herd immunity is probably a
critical host determinant for circumscribing the degree
to which a given GAS strain can successfully transmit
and spread within a human population. Thus, the possibility of future immunization with an M type-based
vaccine is likely to reshape the composition of the GAS
strain population (see “Epidemiology: Strategies for M
Protein-Based Vaccines” below).

GAS (Agent) Factors
A key open question is whether GAS engage in a form of
evolutionary bet-hedging via transmitting a bolus of organisms with a diverse array of transcriptional proﬁles, to increase the odds that at least one physiological form will
colonize and thrive within an individual host. Alternatively,
perhaps there exists a singular transcriptional proﬁle that is
deemed optimal for transmission within the wider human
host population. Or perhaps a mixture of both strategies
is used. Mutations in transcriptional regulatory genes
and/or promoter regions may enhance the transmissibility of GAS (see “Evolution: Short Term” below).
GAS exhibit very high diversity in their cell surface
proteins, in terms of both the presence or absence of a
given protein, and in the sequence heterogeneity among
products of the same locus. Several of the heterologous
cell surface proteins may impart tissue-speciﬁc adaptations (reviewed in reference 50, 51). They also serve as
key epidemiological markers (see next section). Genetic
changes that lead to alterations in the antigenic composition of the GAS cell surface may aid the organism in
escaping herd immunity.

EPIDEMIOLOGY: MOLECULAR MARKERS
The use of serological typing to categorize the pathogens of the Streptococcus genus (i.e., cell wall group

carbohydrate), as well as the strains within a pathogenic streptococcal species, has a long and deep history.
Unlike pneumococci, GAS lack a structurally diverse
and immunogenic polysaccharide capsule. Instead, GAS
express several cell surface proteins which collectively
impart a broad repertoire of antigenic diversity. Underlying the serological phenotype is an extensive history
of horizontal gene transfer (HGT) and recombination
among the cell surface protein genes, plus accumulated
point mutations, that has been shaped (at least in part)
by the strong diversifying selection pressures of the host
immune response. The antigenic structure of GAS cell
surface proteins, and the underlying genotype of both
the cell surface protein and core housekeeping genes, is
highly complex.
Numerous typing schemes have been used to aid in
understanding the epidemiology and underlying organization of the S. pyogenes species. A summary of typing
(and related) schemes, and their applications and limitations, is provided in Table 1. Each epidemiological molecular marker is discussed in detail below.

M Protein
During the 1920s, work began that aimed at understanding the basis for protective immunity to GAS infection. Antibodies raised to extractable surface antigens,
called M proteins, led to opsonophagocytosis of the strain
from which the M protein was derived (52). However,
antibody directed to the M protein of one organism often
failed to confer protection against many other GAS isolates tested. A serological typing scheme arose through
the development of antibodies directed to M proteins
of different isolates. More than 80 distinct M types were
identiﬁed, and protective immunity to GAS infection is, in
large part, M type speciﬁc.
Copurifying with the M type-speciﬁc material was
M-associated protein (MAP), which has two major antigenic forms (53, 54). The MAP I antigen was largely
associated with ARF isolates, and MAP II was highly
prevalent among serum opacity factor (SOF)-producing
organisms. The MAP antigens were subsequently identiﬁed as part of the conserved C repeat region (CRR) of
M protein (55), which occupies the COOH-terminal half
of the surface-exposed portion of M protein. The CRR
has two major antigenic forms known as class I and class
II (56). The structure of M protein is depicted in Fig. 2A.

emm types
A nucleotide sequence-based emm typing scheme that
closely parallels the M serotype scheme was developed ∼2
decades ago (57). emm typing is based on the extensive
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TABLE 1 Epidemiological typing methods for group A streptococcia
Scheme

Description of method

Applications

M serotyping

Limitations

ASMscience.org/MicrobiolSpectrum

Immunoprecipitation, using hyperimmune
No longer in wide use
rabbit antisera
emm typing
Sequencing, yielding >92% nt identity over the
Most commonly used typing method; highly
Based on oligonucleotide primers (via PCR);
ﬁrst 90 bases encoding the processed (mature) reproducible; low cost; large database at CDC;
needs better integration with whole-genome
M protein of an emm type reference strain
can be used to infer emm clusters and emm
sequencing projects
pattern groups with reasonable accuracy
emm subtyping
Sequencing of 180 nt corresponding to the 10
Further stratiﬁes emm types into unique alleles;
COOH-terminal codons of the signal sequence performed in parallel with emm typing; large database
and ﬁrst 50 codons of the mature M protein
and BLAST server are maintained at the CDC
emm pattern
PCR-based mapping, based on 3′ ends of
Assignment of organisms of known emm types
Inferences based on emm type may
grouping
emm and emm-like genes
into groupings that correspond reasonably
occasionally be incorrect; ∼30% of emm
well to tissue site preferences for superﬁcial
types await emm pattern assignment;
infection at the throat and/or skin
PCR-based mapping is laborious and limited
by design of “universal” oligonucleotides
emm cluster typing Based on phylogeny and four bioinformatic
Used to extend information on emm typing; can be
Inferences based on emm type may
criteria, related to surface-exposed portion
easily inferred from emm type; binding motifs can
occasionally be incorrect; ∼29% of
of M proteins; corresponds to binding by
be used to infer binding properties of M proteins
emm types await emm cluster assignment
several human serum proteins
SOF typing
Inhibition of the serum opacity reaction by
No longer in wide use
hyperimmune rabbit serum
sof type assignment needs to undergo
sof typing
Sequencing of ∼700 bp region near
Data can be generated though sequencing of PCR
products or whole-genome sequencing
standardization; evidence for extensive
5′ end of sof
recombination within the sof type region
T serotype
Bacterial cell agglutination, using
In limited use by specialized laboratories,
Inconsistent results; labor-intensive;
hyperimmune rabbit antisera
to supplement emm typing
hyperimmune serum is limited and
diﬃcult to standardize
FCT region typing PCR-based mapping; whole
Can be used as an initial step in further
Assignment of the FCT region needs to
genome sequence
characterization of pilin genes
undergo further deﬁnition and standardization
FCT gene typing
Sequenced-based
Under development for all pilin subunit
and adhesin genes
MLST
Nucleotide sequence of seven (partial)
Used to deﬁne “clones” (i.e., STs) and clonal complexes Provides only a small snapshot of the core
housekeeping genes, from PCR products
(i.e., CCs); often coupled with emm type; alleles are
genome; isolate database is skewed toward
or whole-genome sequences
assigned via simple web-based user queries and
unique genotypes (i.e., not population-based)
curation; database of alleles, STs, and isolates
is maintained on PubMLST server (Oxford)
Whole-genome
Complete or partial genome assembly
Phylogenetic relationships of closely related organisms Core genome deﬁnition lacks standardization
sequencing
via the core genome sequence; investigations
for the diverse range of strains in the species;
of local outbreaks and widespread epidemics;
assembly problems in regions of extensive
routine surveillance; pipelines for analysis of
sequence diversity and/or recombination;
typing and antibiotic resistance genes
bioinformatic analysis can be time-consuming
nt, nucleotide.
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FIGURE 2 M protein structure and emm pattern gene arrangements. (A) Key features of M
protein are shown, including the type-speciﬁc determinants, cell wall-spanning domain,
and C repeat region. (B) Chromosomal arrangement of emm and the ﬂanking emm-like
genes (mrp, enn) gives rise to ﬁve emm patterns, which form three main groupings (A-C,
D, E). Transcription of emm and emm-like genes is positively regulated by Mga, which is
encoded by mga, which lies immediately upstream of the emm region.

nucleotide sequence differences at the 5′ end of the emm
gene, whereby a unique emm type is deﬁned as having
<92% nucleotide identity to any other emm type, over
the sequence corresponding to the ﬁrst 30 codons of the
mature M protein (Fig. 2A). Virtually all contemporary
epidemiological studies deﬁne GAS isolates according to
their emm type. Currently, there are ∼243 recognized
emm types (58).

Identiﬁcation of the emm gene is not always obvious,
and the problem can be due to paralogous emm-like
genes mapping immediately upstream (mrp) or downstream (enn) of emm in numerous GAS strains (see next
section; Fig. 2B). Confusion about emm type assignments has arisen wherein enn is directly fused to the 5′
end region of emm as the result of DNA excision arising
from recombination between the emm and enn genes.
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Among the ∼243 emm types recognized to date, there
are ∼1,632 distinct allelic forms of the emm type-speciﬁc
region, known as emm subtypes (58). The emm subtype
alleles are based on sequence differences relative to the
typing reference, within a 180-bp segment corresponding to the last 10 codons of the predicted signal peptide
coding region and the ﬁrst 50 codons corresponding to
the NH2-terminus of the mature M protein molecule
(59).

emm patterns
Many strains of GAS have emm-like genes (mrp, enn)
positioned immediately upstream and/or downstream of
emm on the chromosome (60–63). Near the 3′ end of
each emm and emm-like gene lies a region that encodes
one of four divergent cell wall-spanning domains that
can be distinguished by oligonucleotides (60, 64). Using
a PCR-based mapping approach, the content of emm
and emm-like genes and their arrangement on the
chromosome was determined for GAS isolates of many
different emm types. The resulting emm region maps are
referred to as “emm patterns”; three major emm pattern
groupings are recognized (Fig. 2B). M proteins of emm
pattern E tend to be class II, whereas the emm patterns
A-C and D groupings largely overlap with the class I
CRR (60).
To date, the emm pattern genotype has been ascertained for GAS isolates of 170 of the ∼243 recognized
emm types (Table 2). With only two exceptions uncovered thus far (emm54, emm218), multiple isolates
sharing the same emm type also share the same emm
pattern grouping. The majority of emm types are represented by emm pattern groups D and E, accounting
for >75% of the emm types analyzed.

emm clades and clusters
An emm cluster typing system was recently developed,
based on the entire surface-exposed portion of M protein and its capacity to bind six human serum proteins (65). Phylogenetic analysis of >1,000 emm genes
corresponding to 174 emm types reveals 2 main clades
TABLE 2 Distribution of emm types among emm pattern

groups for 170 emm types.
emm pattern group

No. of emm types
represented

% of total

A–C
D
E
Rearranged (REA)
A–C and D

35
64
67
2
2

20.6
37.6
39.4
1.2
1.2

(X and Y), and 16 well-supported clusters, accounting
for 82% of the emm types analyzed. The relationships
between emm clades, clusters, and patterns for 174 emm
types are illustrated in Table 3. Nearly all pattern E emm
types (98%) belong to clade X, whereas 92% of pattern
A-C emm types are clade Y.
In contrast to patterns A-C and E emm types, the
pattern D emm types are present in both clades X and Y
(Table 3) (65). The highly specialized plasminogenbinding emm cluster D4 of clade Y represents the largest
emm pattern D grouping (n = 30 emm types). Within
clade X, emm clusters E5 and E6 constitute a second
group of pattern D emm types (n = 14); these two clusters include emm types of other pattern groups as well.
Most of the remaining pattern D emm types are interspersed throughout clade Y (n = 16). Overall, the emm
cluster scheme, based on the phylogeny of the entire
surface-exposed portion of M protein, is highly consistent with the emm pattern scheme that is based on the
COOH-terminal peptidoglycan-spanning domain of
emm and emm-like ﬂanking genes.
The emm cluster typing system is easy to implement since the emm cluster can be inferred from the emm
type (66–69). Importantly, the emm type → emm cluster
scheme is also highly informative of the functional capacity of the M protein molecule, based on consensus
binding motifs for numerous human host plasma proteins (65).

M protein functional domains
As summarized in recent reviews (63, 70), the surfaceexposed non-type-speciﬁc portion of M proteins (i.e.,
central region) contains functional domains that bind
human host proteins such as IgG (various subclasses),
IgA, plasminogen, and ﬁbrinogen. The M type-speciﬁc
determinants at the NH2-terminus bind two complement regulators, C4b-binding protein (C4BP) and factor
H-like 1.
Binding capacities strongly correlate with emm cluster
(65). For example, binding of human IgG is mostly restricted to M proteins of emm clusters E1 through E6.
Similarly, binding of C4BP is limited to M proteins of
emm clusters E1, E3, E4, and E6. IgA binding is evident
only in emm clusters E1, E4, and E6 products, whereas
ﬁbrinogen binding is restricted to M proteins of clade Y,
and plasminogen binding is restricted emm cluster D4
(51, 65).
Although much less is known about the M-like proteins Mrp and Enn (Fig. 2B), binding properties shared
with M protein have been described (reviewed in reference 63), and in some instances, they may use similar
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TABLE 3 Distribution of emm clusters relative to emm pattern groups, for 174 emm types

emm cluster

emm clade

No. of
emm types

E1
E2
E3
E4
E5
E6
singletons
D1
D2
D3
D4
D5
A-C1
A-C2
A-C3
A-C4
A-C5
Singletons
Outliers

X
X
X
X
X
X
X
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Outlier

5
15
19
17
7
18
4
3
5
2
31
3
2
2
5
5
3
22
6

No. of
emm types:
pattern A–Ca

No. of
emm types:
pattern D

No. of
emm types:
pattern E

0
0
0
0
2
1
0
0
0
0
0
1
2
2
5
5
1
15
2

0
0
0
0
3
11
1
2
5
2
30
2
0
0
0
0
0
5
3

5
15
18
17
0
6
3
0
0
0
0
0
0
0
0
0
0
0
1

Other emm pattern
(no. of emm types)b

ND (1)
REA (2)

A–C and D (1)

ND (1)

ND (2)
A–C and D (1); ND (1).

emm pattern assignments are based on references 65, 126, and 127.
ND, not determined; REA, rearranged.

a

b

binding motifs. Additional investigation of the structure
and functional binding properties of the M-like proteins,
and structure of the mrp and enn genes, may eventually
lead to a higher-resolution typing scheme that includes
the entirety of the emm chromosomal region.

Serum Opacity Factor
SOF promotes the opaciﬁcation of serum, wherein the
serum opacity reaction can be neutralized by hyperimmune antiserum produced in animals (71). Not all
GAS strains produce SOF, but SOF typing was often
used as an adjunct for strains that posed challenges for
M typing. Of note, SOF producers have a strong association with strains that harbor the MAP II antigen (72).
In addition, SOF-producing strains tend to exhibit diminished beta-hemolysis (73).
More recent studies show SOF to be a proteinaceous
virulence factor that is either bound to the GAS cell surface or secreted. SOF has an enzymatic domain that
interacts with high-density lipoprotein, leading to the
opaciﬁcation of serum, plus a ﬁbronectin-binding domain (74–77). The genes encoding M protein (emm) and
SOF (sof) map ∼15 kb apart on the GAS chromosome;
as with emm and emm-like genes, transcription of sof is
positively regulated by the Mga regulon (78, 79). sof
types have been deﬁned based on ∼600 to 750 bp positioned near the 5′ end of the sof gene (80). However,

sof typing is far less developed than emm typing, and
attempts to generate a well-supported phylogeny for the
sof type-speciﬁc determinants have largely failed due to
extensive intragenic recombination (81).
The relationships between the presence or absence of
SOF activity, or the sof gene, and the emm pattern and
emm clade as inferred from the emm type, are summarized in Table 4. Based on the strong associations between the MAP II material, class II M proteins, and emm
pattern E (60), it is not surprising that there are strong
correlations between emm pattern E and the presence of
the sof gene and/or a positive serum opaciﬁcation reaction (50, 80, 82, 83). Exceptions include several sofpositive strains within emm cluster E6 that are assigned
to the emm pattern D grouping via PCR-based mapping
(emm59, emm81, emm85); emm12 isolates (pattern
A-C) have an inactive sof gene. Despite the close genome
map positions of sof and emm, a single emm type can be
found in association with more than one sof type and
vice versa (80), indicative of HGT of emm or sof to new
genetic backgrounds and intraspecies recombination
within the greater emm region.

T-Antigens
T-typing is based on agglutination of trypsin-treated
GAS cells with hyperimmune rabbit serum (84, 85). The
T-typing antisera is produced by immunization with

ASMscience.org/MicrobiolSpectrum

9
Downloaded from www.asmscience.org by
IP: 64.118.223.196
On: Wed, 07 Nov 2018 01:48:52

Bessen et al.
TABLE 4 Relationships between SOF/sof and emm patterns and cladesa
emm type-based
grouping

No. of emm
types

% SOF activity
positive

% sof gene
positive

SOF/sof positive
emm types

SOF/sof negative
emm types

Pattern A–C
Pattern D
Pattern E
Clade X
Clade Y

22
42
48
57
56

0
7.3
97.9
87.7
0

5.6
7.1
97.9
87.7
1.8

12b
59, 81, 85
All others
All others
12

All others
All others
15
15, 34, 42, 51, 65, 67, 99
All others

Based on analysis of 113 emm types, as reported in reference 83.
The SOF product of sof12 is typically inactive.

a

b

trypsin-treated GAS cells, followed by adsorption of
antisera to undigested GAS cells of different T types; ∼22
T types have been serologically deﬁned. The T6 antigen
gene (tee6) was the ﬁrst one cloned (86) and was subsequently mapped to a region of the GAS genome that had
been previously characterized as having genes encoding microbial surface components recognizing adhesive
matrix molecules that bind ﬁbronectin and collagen (87–
89). The acronym FCT (fibronectin-binding, collagenbinding, T-antigen) is widely used to describe this genome
region (87). SDSE isolates also express similar T-antigens
(90), as do group B streptococci (91, 92).
T-antigens are equivalent to pili. Within the FCT region lie several genes that contribute to the production
of pili whose assembly is mediated by sortases (48) (reviewed in references 93–95). Seven FCT region forms are
depicted in Fig. 3 (82, 92); the FCT-3 and FCT-4 regions
are associated with the vast majority of emm types (82).
For the most prevalent FCT region forms (i.e., FCT-1, 3,
4, and 5) found among GAS strains of different emm
types, the pilin backbone (BP) proteins and many of the
ancillary pilin (AP) proteins that act as adhesins display
extensive sequence heterogeneity (87, 92, 96).
The relationships between T-typing sera and recombinant pilin proteins has been examined (48, 92, 97).
In perhaps the most thorough study to date, using 15
T-typing sera, agglutination of trypsin-treated GAS cells
corresponds most closely to reactivity with both the BP
and AP1 (presumptive adhesin) subunits by immunoblot
(92). For a T3/13/B3264 strain (Alab49; FCT-3), the
recombinant AP1 subunit (i.e., Cpa) is strongly reactive
by immunoblot with each of the anti-T3, anti-T13, and
anti-B3264 sera, whereas the BP (i.e., FctA) is bound
by anti-T3 sera only (97). However, there is very little
amino acid sequence homology between Cpa and FctA,
as is also the case for the other adhesin-backbone pilin
subunit pairs (82, 98).
That some T-typing sera display immunoreactivity
to multiple recombinant pilin proteins seems likely due
to incomplete adsorption of the antisera and/or the

presence of antigenic epitopes shared among pilin subunits belonging to the variety of GAS strains used for
immunization. Possible unmasking of immunological
determinants via the trypsin pretreatment used in the
cell agglutination assay may further complicate efforts
to draw direct connections between T-serotypes and
speciﬁc pilin protein variant forms. Adding even further
complexity to the T-typing scheme are the numerous
GAS isolates that agglutinate with multiple T-typing
sera, such as T3/13/B3264 or T8/25/Imp19; many other
T-serotype combinations (>60 in total) are also observed
(83). Overall, the T-typing sera displaying the least crossreactivity with multiple pilin forms are T2, T4, and T6
(92); these appear to be best represented by the FCT-6,
FCT-5, and FCT-1 regions, respectively (Fig. 3), although
within these FCT regions lie at least some extensive pilin
gene diversity (see, e.g., reference 99 for FCT-1).
T-serotype and M-serotype and/or emm-type data for
GAS isolates (n > 20,000) from two large collections (the
CDC and the University of Minnesota reference laboratory), recovered in the United States from about the
1980s to the mid-2000s (83), was collated and is summarized in Table 5. There are no strict sampling criteria
for this assemblage; it seems reasonable to assume that
it largely consists of a combination of isolates causing
iGAS disease and strains with high prevalence. In this
skewed, non-population-based sample, the dominant
T types among emm pattern A-C strains are T1, T11
and/or T12, and T3, T13, and/or B3264, reﬂecting
the highly prevalent M/emm types M1, M12, and M3,
respectively.
T-non-typeable (TNT) GAS probably represent isolates that fail to produce pili; they account for ∼9%
of total isolates but >20% of emm pattern D isolates
(Table 5). The relatively large numbers of TNT isolates
among pattern D strains may reﬂect the disproportional
presence of nra (82); Nra functions as a repressor or
activator of pilus gene expression in a strain-dependent
manner (88, 100). Nearly 60% of emm pattern D
isolates are T3, T13, and/or B3264 (Table 5), which
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FIGURE 3 Structure of the pilus-encoding FCT region. Seven forms of the FCT region are
shown. For pilus structural protein genes: bp, tee, and fctA, backbone pilins; ap1, ap2, fctX,
cpa, and fctB, ancillary pilins. In FCT-2, ap1, bp, and ap2 have sequence homology with
cpa, fctA, and fctB, respectively, although divergence is high (82). Pilin adhesins include
FctX from FCT-1, AP1 from FCT-2, and Cpa from FCT-3 and FCT-4. Pilin subunits that
anchor the pilus shaft to the cell wall include AP2 and FctB (249). Fibronectin-binding
protein genes include prtF1 (sometimes designated sfbI), prtF2 (sometimes designated
pfbp), and possibly others that remain to be classiﬁed.

appears to be largely represented by the FCT-3 region
form (82, 87, 92, 97). The most frequent M/emm types
among pattern E isolates of this collection are M4 and
M28 (83), which largely reﬂects the dominance of the
T4 and/or T28 serotype grouping (Table 5). Several
correlations between individual loci within the FCT region and emm pattern and/or emm type have been noted
(50, 82, 92, 101).
Within an emm cluster group, there can be a very
wide array of T types (based on Table 5; detailed data
not shown) (83). For example, the emm cluster E3
isolates (13 emm types) are found in association with T5,
T27, and/or T44 (28%); TNT (16%); T8, T25, and/or
Imp19 (11%); T14 (11%); T9 (9%); T4 and/or T28
(9%); T3, T13, and/or B3264 (6%); and T11 and/or
T12 (4%), among others. In contrast, cluster D4 isolates
(21 emm types, all encoding plasminogen-binding M

proteins) are far more homogeneous, with 72% associated with T3, T13, and/or B3264 (another 16% are
TNT). Although emm genes within a cluster are more
closely related to each another than to emm of other
clusters, the extent to which surface pili contribute to the
overall antigenic cell surface repertoire appears to vary
widely by cluster.
For GAS sharing the same emm type, individual isolates often differ in their T-serotype (80, 83). For example, while a substantial majority of M/emm type 4 isolates
from the Table 5 study are T4, there are other M/emm4
isolates that have T types T4/28, T8/25/Imp19, T3/13,
and TNT (83) (detailed data not shown). M/emm4
isolates typically have sof4, but there are exceptions here
as well (80). The unique combinations of M/emm, SOF/
sof, and T types is indicative of HGT of the epidemiological marker genes among GAS.
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TABLE 5 Relationships between emm pattern and T types for >20,000 GAS isolatesa
T type

% Total

% Pattern A–C

% Pattern D

% Pattern E

T1
T2
T6
T9
T14
T15
T18
T22
T23
T3, 13, and/or B3264
T4 and/or 28
T5, 27, and/or 44
T8, 25, and/or Imp19
T11 and/or 12
Nontypeable

18.73
3.30
6.19
0.82
0.88
0.00
0.59
0.02
0.07
16.10
15.88
4.36
6.60
18.17
8.29

34.64
0.00
11.09
0.00
0.11
0.00
1.10
0.00
0.12
17.14
0.15
4.90
1.13
20.80
8.83

0.93
0.00
1.97
1.39
4.29
0.00
0.00
0.00
0.00
58.63
3.59
0.70
2.90
4.52
21.09

0.14
7.85
0.34
1.81
1.55
0.00
0.00
0.04
0.00
10.75
37.24
4.03
13.82
16.17
6.25

aBased on analysis of T-serotyping data (83) according to emm pattern groups or clades inferred from M or emm type (65, 126, 127), for 21,231 isolates, whereby 271
isolates had >1 grouping and were counted more than once. M or emm types ranged from types 1 through 124.

Unlike M type-speciﬁc antibodies, there is no known
human host protective effect mediated via T type-speciﬁc
serum; this may be a consequence of immunoreactivity
directed toward trypsin-treated target antigens that
are not encountered during natural infection. However,
antiserum raised to recombinant pilin subunits or intact
pili can be protective in experimental assays (48, 102).
Shortcomings of the T-typing cell agglutination assay
include a general lack of good resolution, the time-consuming process, and the requirement for standardized
rabbit serum. Because T-typing sera display high levels
of immunological cross-reactivity to different recombinant pilin polypeptides, and many GAS isolates agglutinate with multiple T-typing sera, it can be difﬁcult to
predict the FCT region genotype form based solely on
the T-agglutination pattern.
At present, there is no single widely recognized genotyping scheme for the FCT region form and pilin genes
(35, 82, 92, 96), but the need for one seems quite compelling given the importance of the FCT region in strain
diversity as well as virulence.

MLST is based on the nucleotide sequences of seven
(partial) core housekeeping genes (104). MLST data are
maintained at a user-interactive website (www.pubmlst
.org/spyogenes) and currently lists 966 distinct sequence
types (STs) (105); numerous investigators from throughout the world have generously contributed to this rich
data set. Using goeBURST (106), 133 clonal complexes
(CC) as deﬁned by single locus variants (SLVs) have been
detected. Figure 4 provides a chromosomal map of the
relative positions of the core housekeeping genes and the
emm and FCT regions.
FIGURE 4 Chromosomal map of the epidemiological marker
genes of GAS. Open circles represent the seven core housekeeping genes used in MLST (104). The sof locus, when
present, lies ∼15 kb upstream of emm. The FCT region, which
encodes pilus structural proteins and pilus biosynthetic
enzymes plus other adhesins and transcriptional regulators,
ranges in size from ∼11 to 16 kb. The FCT region lies ∼250 to
300 kb from the emm region, on the opposite side of the
origin of replication (ori). GAS genomes range in size from
∼1.8 to 1.9 Mb.

Multilocus Sequence Typing and
Core Housekeeping Genes
The ﬁrst study to examine the population structure of
GAS utilized multilocus enzyme electrophoresis (103).
Isolates recovered from cases of severe iGAS disease
correspond to several distinct lineages as deﬁned by
electrophoretic type. The multilocus enzyme electrophoresis approach was replaced by the more standardized multilocus sequence typing (MLST). For GAS,
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A given pattern A-C emm type has a high tendency
to be associated with a single ST or CC (104, 107, 108).
However, the relationships between emm type and ST
are not strict, and emm types of pattern groups D and
E are often found in association with distant STs (see
“Lateral Movement of emm” below). These data parallel
ﬁndings on the complex relationships between M/emm
types, sof types, and T types (80, 83) and, taken together,
provide supporting evidence for the HGT of emm from
one genetic background to another.

Whole-Genome Sequences
The ﬁrst completely assembled GAS genome was that of
an emm1 isolate (109). In the years that followed, numerous complete GAS genomes were reported for many
of the most prevalent emm types found in resource-rich
nations (updated listings are presented in recent reviews
[50, 110]). Via next-generation sequencing technologies,
many thousands of genomes of GAS isolates have undergone nucleotide sequence determination (e.g., 24, 30,
111–115). In nearly all studies, core genome sequences
are compared for isolates sharing the same emm type,
and numerous key insights on genetic changes that underlie enhanced transmission and/or virulence have been
uncovered. The core genome data can be used to build
evolutionary models of outbreaks and epidemics (see
“Epidemiology: Building Evolutionary Models” and
“Evolution: Short-Term” below).
A core genome MLST has not yet been developed for
GAS. Although it is a reasonable concept for some
bacterial species, its utility for GAS would probably be
rather limited due to the ultraﬁne resolution this approach would provide for GAS, coupled with the extensive genetic recombination that characterizes this
species. Core genome-based phylogenies of GAS of different emm types and/or CCs tend to yield lineages with
deep branches, indicative of large genetic distances (50,
110, 111, 116).
The use of genome sequence data for surveillance
of GAS has begun (35, 117–120). The CDC recently
implemented a whole-genome sequence-based typing
scheme for population-based iGAS strain surveillance
conducted through the Active Bacterial Core program
(35). For large-scale strain surveillance, the ability to
obtain detailed information on typing and resistance
features within a single output, from a single raw data
input source, has largely precluded the need for multiple
typing protocols and antibiotic susceptibility testing.
The GAS typing pipeline automatically restricts an emm
type to the sequence linked to emm consensus primer 1
(121) to improve accurate identiﬁcation of emm and

assigns an emm subtype (i.e., allele) as well. Partial
sequences of BP genes and sof are also captured. In addition to emm subtype, the emm-like genes and MLST
alleles and STs are identiﬁed, as is gacI, which is speciﬁc
to CHO-A biosynthesis. Among numerous other genes,
antimicrobial resistance determinants are also assessed.
A key feature of genome sequence-based active iGAS
surveillance is the capacity to detect temporally and
geographically related GAS clusters. For GAS isolates
that are nearly identical at the single nucleotide polymorphism (SNP) level, the circumstances of where and
when the isolates were recovered can be examined to
help establish whether there exist disease clusters that
may be well suited for an intervention (e.g., health care
facilities, vulnerable patient populations such as the
homeless, and IVDUs). Thus, next-generation sequencing coupled with an appropriate bioinformatics pipeline
can be used as an autodetection tool to help guide public
health interventions.

EPIDEMIOLOGY: GLOBAL TRENDS
Infection at the Epithelium
of the Throat and Skin
Past studies show that GAS strains bearing certain M
types have a strong tendency to cause pharyngitis but
not impetigo. Similarly, there are M types often recovered from impetigo skin lesions but rarely from cases of
tonsillopharyngitis (8, 122, 123). This observation gave
rise to the important concept of classical throat and skin
strains that are largely distinct from one another in their
epidemiological and disease associations.
There are strong correlations between emm pattern
groups A-C and D and recovery from cases of pharyngitis versus impetigo, respectively (50, 124, 125). Since
the emm type is highly predictive of the emm pattern
group for nearly all emm types examined (126, 127),
reasonable inferences can be made about emm pattern
grouping based on knowledge of emm types. Such inferences were made on an expanded scale for >5,000
GAS isolates derived from cases of pharyngitis or impetigo in 29 population-based surveillance studies from
throughout the world (Table 6). In 23 studies on pharyngitis, emm pattern A-C and D isolates constituted
a mean average of 41% and 6%, respectively. In six
studies of impetigo, the mean average for emm pattern
A-C and D isolates was reversed, at 9% and 47%.
For pharyngitis versus impetigo groups, the difference
between the fraction of A-C and D isolates in each
surveillance study is highly signiﬁcant (Table 6). emm
pattern E isolates account for almost equal fractions
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TABLE 6 emm pattern assignments for GAS recovered in 29 population-based surveys for pharyngitis or impetigoa
Disease
association

No. of
studies

Mean average
% pattern A–C

Mean average
% pattern D

Mean average
% pattern E

Paired t-test
Paired t-testb Paired t-test
(% pattern
(% pattern
(% pattern
A–C versus D) A–C versus E)c D versus E)

Pharyngitis
Impetigo

23
6

40.5 ± 19.8
9.3 ± 6.7

5.8 ± 12.0
47.4 ± 8.1

53.7 ± 16.0
43.4 ± 7.0

<0.001
<0.001

N.S.
n/a

n/a
N.S.

aBased on references 50 and 131. The 29 studies meet the following criteria: (i) isolates are clearly deﬁned for recovery from cases of pharyngitis (or tonsillitis) or impetigo,
and (ii) at least 25 isolates can be assigned to an emm pattern group based on emm type.
bPaired t-tests are two-tailed.
cN.S., nonsigniﬁcant; n/a, not applicable.

of throat and skin infections; the mean average percentage of emm pattern E isolates shows no signiﬁcant
difference from pattern A-C isolates at the throat or
pattern D isolates at the skin.
Based on the strong clinico-epidemiologic associations,
the emm pattern A-C strains are designated “throat specialists,” whereas the pattern D strains are “skin specialists.” As a group, emm pattern E strains are considered
“generalists.” Importantly, the emm pattern serves as a
useful genotypic marker for the preferred tissue site of
infection by GAS (32, 50, 124, 125, 128).
The emm cluster typing scheme can also be applied
to the 29 population-based surveillance studies on GAS
pharyngitis and impetigo (Table 7). Both pharyngitis
and impetigo isolates are almost evenly split between
clades X and Y, reﬂected by fractional ratios of percent
pharyngitis to percent impetigo approaching 1. However, within clade Y, the distribution of pharyngitis and
impetigo isolates are highly skewed among the clusters,
with clusters A-C1-5 disproportionately represented by
pharyngitis isolates, and clusters D1-5 disproportionately represented by impetigo isolates.

Several predicted binding motifs within M protein
strongly correlate with emm clusters (65). Based on the
29 population-based surveys, the fractional ratio of
pharyngitis to impetigo isolates is highly skewed for the
ﬁbrinogen-binding clusters of clade Y (high ratio value,
with pharyngitis dominant) and the plasminogen-binding cluster D4 (low ratio value, with impetigo dominant)
(51). The differential binding properties for human host
proteins, by M proteins in accordance with disease, are
potential determinants of tissue tropism. How modulation of the coagulation-ﬁbrinolytic pathways (129) may
translate into GAS tissue tropisms is an active line of
inquiry.

Invasive Disease
As detailed above (“Ecology: Host Tissues and Diseases”), iGAS disease is extremely rare relative to GAS
infection at the two primary ecological niches. When
iGAS disease does occur, it is largely a transmission dead
end, with the possible exception of direct contact transmission via open cutaneous wounds among underserved
adult populations. Thus, iGAS infections have minimal

TABLE 7 emm cluster and clade assignments for GAS recovered in 29 population-based surveys for pharyngitis or

impetigoa

emm
clade

emm
cluster

No. of
isolates

No. of
pharyngitis
isolates

ALL
X
Y
Outlier
X
X
Y
Y
Y

ALL
ALL
ALL
ALL
E1-6
Singletons
A-C1-5
D1-5
Singletons

5,439
2,804
2,608
27
2,802
2
1,849
344
415

4,674
2,433
2,239
2
2,432
1
1,817
49
373

No. of
impetigo
isolates

% of total
pharyngitis

765
371
369
25
370
1
32
295
42

100
52.1
47.9
0.04
52.0
0.02
38.9
1.1
8.0

% of total
impetigo

Fractional ratio
of pharyngitis
to impetigob

Fractional
ratio of
impetigo to
pharyngitis

100
48.5
48.2
3.3
48.4
0.1
4.2
38.6
5.5

n.a.
1.07
0.99
n.d.
1.08
n.d.
9.29
0.03
1.45

n.a.
0.93
1.01
n.d.
0.93
n.d.
0.11
36.78
0.69

Based on references 50, 51, and 135 and Table 6.
Calculated as the ratio of the percentage of total pharyngitis isolates to the percentage of the total impetigo isolates.
cn.a., not applicable; n.d., not determined.
Key ratios are highlighted (bold)
a

b
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impact on shaping the long-term evolution of GAS. The
occurrence of iGAS disease is strongly affected by host
risk factors and to a lesser extent by the genotype of the
infecting GAS strain.
In the United States and Europe, most iGAS disease depends on transmission of GAS via a respiratory
route (Fig. 1). Whole-genome sequencing of hundreds of
GAS isolates has provided important details on genetic
changes that enhance transmission and/or invasiveness
(see “Evolution: Short-Term” below). The invasive index value provides insight on whether a GAS strain has
an inherent ability to better gain access to deep tissue
relative to its overall prevalence in the host population
(22, 130). The emm types associated with iGAS disease
have been intensively studied and are well described (e.g.,
131–133).
Nonbullous impetigo caused by GAS usually arises
in young children in tropical or subtropical climates.
GAS can also cause slightly deeper cutaneous infections
that are considered “pyoderma,” and while they are not
considered part of the iGAS disease spectrum, these
cutaneous infections are distinct from typical impetigo
in terms of patient demographics (i.e., adult, temperate
regions) and host risk factors (e.g., IVDU, homeless,
military) (23, 24, 134–136). Of interest is the strong
association between certain pattern D emm types (speciﬁcally, emm59 and emm81) and recent infections and
outbreaks of deeper cutaneous infections. The emm59
and emm81 types are notable for their grouping in
cluster E6 and tend to harbor sof as well; conceivably,
these are “super-specialist” strains containing a hybrid
mix of virulence factors that shift the modes of transmission and GAS disease course. Most other GAScausing skin infection outbreaks among IVDUs are
sof-positive emm pattern E strains (137, 138).

Acute Rheumatic Fever
Acute rheumatic fever (ARF) follows an inadequately
treated GAS infection of the URT in a genetically predisposed host by ∼3 to 6 weeks and can lead to rheumatic heart disease (RHD) via autoimmune attack of the
heart valves (139–143). With >500,000 annual deaths,
half attributed to RHD, GAS ranks high among all infectious causes of morbidity and mortality. Recent estimates of the prevalence of RHD are ≥15 to 30 million
cases worldwide (15, 144–146); RHD is the leading
cause of mortality from acquired heart disease in individuals <50 years old (147) and of all cardiovascular
disease in children in resource-poor nations (148). Today, ARF and RHD are largely diseases of poverty, with
an occasional resurgence in disease elsewhere (149).

Early epidemiological studies of ARF outbreaks in
institutional settings showed that only a subset of GAS
strains trigger ARF (11, 55, 140, 150–156). Historically,
“rheumatogenic” GAS strains were referred to by their
M protein serotypes, with M3, M5, M6, and M18 being
highly prevalent. The concept of “nonrheumatogenic”
strains is exempliﬁed by the RHD patients of Irvington
House during the preantibiotic era, who experienced a
GAS outbreak (M type 4) in the absence of recurrent
ARF attacks (155). Of ten M types often associated with
ARF (M types 1, 3, 5, 6, 14, 18, 19, 24, 27, and 29
[157]), nine are emm pattern A-C (one is pattern E);
of ﬁve relatively common M types that are rarely associated with ARF (M types 2, 4, 12, 22, and 28 [157]),
four are emm pattern E (one is emm pattern A-C) (126,
127).
ARF-associated isolates recovered in Hawaii differ
from the classic rheumatogenic emm types (158).
Atypical emm types are also found in tropical Australia,
where the prevalence of RHD is among the highest in the
world (159). Over time, it has become much less clear
which emm types are best assigned the “rheumatogenic”
label, even though it is widely accepted that not all GAS
strains trigger ARF in a genetically susceptible host (150,
155).
The potential role of GAS skin infection in triggering ARF and RHD in certain settings (e.g., noninstitutional, tropical) has been an ongoing debate since the
1960s (160). For example, the indigenous population
of Australia suffers from a high incidence of ARF and
RHD, yet GAS is far more frequently recovered from
impetigo lesions than from the throat. Moreover, the
strains recovered from the URT in this host population often belong to the emm pattern D skin specialist
group or pattern E generalists. The epidemiological cooccurrence of GAS skin infections and RHD supports
the idea that impetigo may contribute to this chronic
disease. More extensive studies are needed to better understand skin infections and their potential role in ARF
and RHD. The possibility that the closely related species SDSE might also trigger episodes of ARF or worsen
RHD deserves deeper consideration as well (161, 162).

EPIDEMIOLOGY: DIVERSITY WITHIN
HOST COMMUNITIES
Within a human host community over a narrow time
frame, numerous GAS strains are in circulation. For the
29 population-based collections of GAS recovered from
cases of pharyngitis and impetigo, the number of emm
types and the Simpsons diversity index was calculated
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TABLE 8 emm type diversity within communities for the 29 population-based surveys for pharyngitis and impetigoa
Disease association

No. of studies

Mean average no. of emm types

Mean average D indexb

Pharyngitis
Impetigo

23
6
Unpaired t-test, 2-tailed

17.4 ± 7.8
33.8 ± 8.1
t = 0.0049

0.873 ± 0.065
0.959 ± 0.012
t < 0.001

Based on references50, 51, and 135 and Tables 6 and 7.
Simpson’s diversity index (D) (248) is based on emm types.

a

b

(Table 8). The number of emm types for the impetigo
collections averaged nearly twice that of the pharyngitis collections (t < 0.01, unpaired t-test, 2-tailed). The
Simpson’s diversity index (D), which incorporates the
number of recovered organisms into the calculation, also
shows highly signiﬁcant differences between the impetigo and pharyngitis collections, wherein the impetigo
group has a higher mean average D value (a D value
of 1 reﬂects maximal diversity). An analysis that includes all GAS, irrespective of clinical association, also
shows fewer numbers of emm types accounting for a
large proportion of isolates in resource-rich countries,
where URT infections tend to predominate (131). The
large numbers of circulating emm types is likely the
consequence of expansive GAS strain migration, even
into geographically remote communities (108). The biological basis for the difference in diversity among GAS
in host populations experiencing pharyngitis versus impetigo may be tied to the mechanisms for transmission:
respiratory droplets versus direct contact. It may be that
the respiratory route is more highly efﬁcient, such that
a single infected individual can infect many more new
hosts (i.e., higher basic reproductive rate), and this in
turn leads to dominance by fewer strains, resulting in a
lower D value.

EPIDEMIOLOGY: EVOLUTION
OF MARKERS (emm)
Although emm type diversity within a host community is
relatively low for the emm pattern A-C throat specialists
compared to the pattern D skin specialists (Table 8),
there is relatively high diversity among emm pattern A-C
organisms in terms of the number of emm subtypes (i.e.,
alleles based on the 5′ end of the emm gene) that evolved
worldwide (Table 9). The average mean number of emm
subtypes identiﬁed for pattern A-C strains is 22.3 subtypes per emm type, compared to only 4.0 and 6.9 for
pattern D and E strains, respectively, based on current
data available in the CDC online database (58), which
receives numerous deposits from investigators throughout the world.

The >5-fold difference in the number of emm subtypes
for throat specialists versus skin specialists may be partly
due to sampling bias that skews in favor of GAS invasive
and pharyngitis isolates in resource-rich nations, such as
the highly prevalent emm1 type (pattern A-C). In addition, the tandem sequence repeats that overlap the emm
subtype-determining region of emm5 and emm6 genes
(pattern A-C) are a mutational hotspot due to DNA
slipped-strand mispairing (163). However, biological
factors such as host immune selection promoting immune escape (164) may also play a role.
Nucleotide sequence alignment of emm subtype
alleles for each emm type-speciﬁc region, derived from
>500 global GAS isolates (n = 105 emm types), reveals
average ratios of nonsynonymous substitutions per nonsynonymous site (Ka) and synonymous substitutions per
synonymous site (Ks) of 4.9, 1.5, and 1.3 for emm types
of the emm pattern A-C, D, and E groups, respectively
(107). Thus, diversifying (positive) selection acting on
the emm type-speciﬁc sequence appears to be strongest
for emm pattern A-C strains.
A likely source of diversifying selection acting on the
emm type region is the protective host immune response,
which can drive immune escape. Conceivably, the immunological pressures at the oropharynx (pattern A-C
throat specialists) are more intense than those at the skin
(pattern D skin specialists), although an underlying
molecular mechanism is not presently obvious. Perhaps
herd immunity builds up more quickly with a respiratory
mode of transmission compared to direct skin contact; as herd immunity builds, the number of susceptible
hosts dwindles, leading to more frequent occurrences
of immune escape. In further support of a role for herd
immunity in shaping the emm type content of GAS
populations, newly acquired URT infections in older
children are skewed toward less common emm types,
consistent with exposure and protective immunity to the
more prevalent emm types in early childhood (165).
The collection of M protein types assigned to a
single emm cluster have high sequence similarity relative
to M proteins of other clusters (65). Indeed, an M typespeciﬁc region sharing the same cluster as other M types
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TABLE 9 Relationships between emm pattern or cluster and emm type and subtype
emm grouping
category
Pattern
Pattern
Pattern
Clade
Clade
Cluster
Cluster
Cluster
cluster
Cluster
Cluster
Cluster
Cluster
Cluster
Cluster
Cluster
Cluster
Cluster
Cluster
Cluster
Cluster
Cluster
Cluster
Clade Y singletons
Clade Y singletons
Clade X singletons
a

Name of group

No. of
emm types
represented

No. of emm
subtypes
representeda

Average no. of
emm subtypes
per emm type

A-C
D
E
X
Y
E1
E2
E3
E4
E5
E6
Clade X singletons
A-C1
A-C2
A-C3
A-C4
A-C5
D1
D2
D3
D4
D5
Clade Y singletons
Pattern A-C
Pattern D
Pattern E

35
64
67
85
89
5
15
19
17
7
18
4
2
2
5
5
3
3
5
2
31
3
28
16
8
2

781
253
460
518
1,014
40
84
119
150
15
98
12
7
26
118
111
140
13
22
4
144
6
423
385
16
6

22.31
3.95
6.85
6.09
11.39
8.0
5.6
6.3
8.3
2.1
5.4
3.0
3.5
13.0
23.6
22.2
46.7
4.3
4.4
2.0
4.6
2.0
15.1
24.1
2.0
3.0

Based on the CDC online database (58).

often elicits cross-protective antibodies (see “Epidemiology: Strategies for M Protein-Based Vaccines” below).
Ultimately, this cross-protective effect may aid in the
design of highly efﬁcacious vaccines that have broad
coverage but contain only a limited selection of typespeciﬁc epitopes. Whereas 90% of pattern D and E emm
types belong to 1 of the 16 emm clusters, nearly half
of pattern A-C emm types are standalone and do not
cluster with any other emm type, highlighting once again
a distinct dynamic for the evolution of many pattern A-C
emm types.
Another possible factor at play in shaping the evolution of emm type-speciﬁc sequences is functional constraints, such as those imposed by binding C4BP via the
type-speciﬁc region of numerous M proteins (166–168).
Whole GAS organisms that bind C4BP tend to harbor
M types associated with emm pattern groups D and E
(167). Thus, there may be limits to diversiﬁcation within
M proteins that bind C4BP for the GAS strains that
utilize this virulence strategy to enhance survival. Also,

potentially related to selection pressures acting on GAS
is the ﬁnding that engineered mutants with emm gene
deletions have a (near) complete loss in the antiphagocytic effect for pattern A-C strains, whereas the loss is
only partial for pattern D and E strains (169).
Overall, the throat specialists are characterized by
fewer distinct emm types within a human host community but high diversiﬁcation worldwide within the
type-speciﬁc region (i.e., more emm subtypes). The skin
specialists have about twice the number of emm types
within a community, but diversiﬁcation within the typespeciﬁc region is ∼5-fold lower based on the number
of emm subtypes or Ka/Ks ratios. The emm pattern E
generalists are most similar to the skin specialists in these
values.
The “emm type” and “emm cluster” deﬁnitions are
categorical, and the noted differences between throat
and skin specialists may partly reﬂect the placement of
the categorical “cutoff” value along a continuum of sequence divergence. Factors that shape the GAS popula-
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tion structure, as deﬁned by emm type, likely include
the route of transmission, environmental risk factors,
the host immune response, tissue-speciﬁc host factors,
binding functions of M protein, and intrinsic GAS
factors that inﬂuence mechanisms for genetic change.

EPIDEMIOLOGY: STRATEGIES FOR
M PROTEIN-BASED VACCINES
Numerous vaccine strategies for protection against GAS
infections were recently reviewed (170–172). Brieﬂy,
vaccine strategies can be divided into M protein and
non-M protein target antigens, with the latter including streptolysin O, C5a peptidase, CHO-A, pili, and the
enzyme arginine deiminase (102, 173–178). However,
only the vaccine candidates that incorporate M protein
as the target antigen have attained human clinical trial
status (179).
M protein vaccines based on the conserved antigens
of the CRR (Fig. 2A) have undergone extensive investigation (49, 180–185). Since all M proteins have a CRR,
a CRR-based vaccine has the theoretical advantage of
providing broad coverage against all GAS strains; several formulations are currently, or will soon be, in clinical trials. Potential drawbacks of a CRR-based vaccine
include immune escape. The CRR region of M protein, which includes MAP I/II and the class I/II antigenic
epitopes, is not 100% conserved. For example, among
175 emm types from a worldwide strain collection, there
are 22 alleles of the CRR-based J8 vaccine candidate
(65). Importantly, some of the amino acid residues
within the CRR of the M protein display signatures
of diversifying selection. Immune escape is a possibility
for any vaccine target, and current knowledge indicates
that it deserves careful consideration for a CRR-based
vaccine.
The second category of M protein-based vaccine candidates targets the NH2-terminal type-speciﬁc determinants (179, 186). Pioneering work in the 1940s and
1950s showed that type-speciﬁc serum is responsible for
protective immunity against the homologous emm type
(187–190); in contrast, minimal to no protective effects
were observed for infection by heterologous GAS types.
A 26-valent M type-speciﬁc recombinant polypeptide
vaccine is the only GAS vaccine to have reached phase II
clinical trials, whereupon it was found to be safe and
highly immunogenic (179). The “type-speciﬁc protection” paradigm of GAS immunity has led to concerns
about the potential for low coverage by the multivalent
vaccine, especially in tropical settings, where the number
of GAS emm types can be very high (131, 191–195).

Recent data indicate that cross-protective immunity
between closely related emm types can induce broader
protection via multivalent vaccines than type-speciﬁc
immunity might otherwise predict. An initial hypothesis
on cross-protective immunity was raised following genetic analysis of GAS strains collected in Brazil (196,
197). Cross-protective opsonization by hyperimmune
rabbit antiserum generated via immunization with M
type-based vaccines was subsequently demonstrated
using a 30-valent vaccine (186) and an experimental
4-valent vaccine designed to protect against the 17 emm
types belonging to emm cluster E4 (198).
Superﬁcial skin infection can stimulate a robust antibody response. A recent study of humoral immunity
acquired after impetigo infection in Fijian schoolchildren
demonstrates that 38% of subjects had a ≥4-fold increase in anti-M-type-speciﬁc IgG titers that match the
M type of the infecting strain (199). Importantly, crossprotective emm cluster-speciﬁc immunity was evident
for clusters E4, E6, and D4, although the levels of crossprotection were variable depending on both the patient
and emm cluster. That the cross-reactive immune responses frequently align with emm cluster groups holds
promise for the design of M type-based vaccines having
broad coverage. More data are needed to further solidify
the clinical and experimental ﬁndings obtained to date;
identifying immunoassays to help deﬁne correlates of
protection (CoPs) is a high-priority goal (200). Serotype
replacement may potentially be an issue for GAS following widespread immunization with M type-based
vaccines, as is the case for Streptococcus pneumoniae
and serotype-based capsule vaccines (201, 202).

EPIDEMIOLOGY: BUILDING
EVOLUTIONARY MODELS
MLST data can be used to build models of evolutionary
descent via eBURST or goeBURST, which are clustering
algorithms based on SLVs (and/or double locus variants)
among the seven core housekeeping genes (106, 203).
The single mismatched allele that deﬁnes an SLV pair
can arise by either point mutation or homologous recombination, whereby the latter may introduce >1 SNP.
For GAS, the combined total length of the seven
housekeeping (partial) alleles is 3,134 bp. However,
3,134 bp represents only a fraction of the GAS core
genome; for example, emm3 type iGAS have a core genome of ∼1,645 kb (115), which is ∼524-fold longer
in sequence than the MLST alleles combined. Based on
these values, it can be estimated that an MLST-deﬁned
SLV pair of GAS would differ by an average minimum
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of >500 SNPs within its core genome if genetic change
were strictly due to point mutation or intraspecies recombination between very closely related organisms.
However, if there was extensive HGT and recombination between more distally related GAS, the number
of SNPs that differentiate the SLV pair is expected to
be even higher. Given that the core genome of emm3
type iGAS strains has an estimated 29 to 133 SNPs
per isolate (i.e., short-term evolution) (115), the models
for evolutionary descent based on the SLVs of MLST
using only seven core housekeeping genes may best
capture intermediate stages of evolution, which can be
quite informative.
MLST data in combination with epidemiological
marker genotypes can be compared to whole-genome
sequence data. A good example for comparison is the
emm89 strains causing iGAS disease in Europe and the
United States, which underwent a marked increase in
prevalence during the 2010s (30, 31, 111, 204). Using
the ST and GAS isolate data deposited at www.pubmlst
.org/spyogenes (105), a goeBURST plot that includes
the recent epidemic emm89 strains is shown in Fig. 5A.
The newly emerged epidemic clade of emm89 corresponds to ST101 (and its descendants). Based on demographic information (i.e., dates of recovery), it seems
reasonable to assume that ST407 is ancestral to ST101.
Notably, ST407 is recovered in association with two distinct emm types: at least one other ST407 GAS isolate in
the PubMLST database has emm78 in place of emm89,
as do several other SLVs and double locus variants of
ST407. Alignment of the 180-bp emm subtype regions of
emm78.0 (ST253) and emm89.0 (ST407, ST101) reveals
<60% identity for both nucleotide and amino acid sequences, indicative of substantial divergence (ClustalW;
data not shown) and supporting a model wherein
emm78 and/or emm89 underwent HGT and recombination onto an ST407-related genetic background. Both
emm78 and emm89 are emm pattern E but belong to
different emm clusters (E1 and E4, respectively).
Examination of the FCT regions of ST407 and ST101
emm89 type GAS isolates reveals highly divergent Cpa
and FctA proteins, corresponding to the AP1 and BP
subunits of pili, respectively (Fig. 5B). The distinct Cpa
and FctA forms appear to coincide with T serotypes T11
(ST407) and T13 (ST101) (35). The housekeeping gene
locus that distinguishes ST407 and ST101 is yqiL, which
lies adjacent to the FCT region (Fig. 4); yqiL01 (ST401)
differs from yqiL03 (ST101) by three nucleotide substitutions, highly suggestive of diversiﬁcation via recombination. In contrast to the eBURST analysis of MLST
data, whole-genome sequencing and analysis of the core

genomes of emm89 isolates provides a much higher level
of resolution (30, 35, 111, 112). Importantly, several
SNPs and indels that distinguish the emm89 clade 2 →
clade 3 transition lead to alteration of virulence factor
expression: loss of the hyaluronic acid capsule (ΔhasA)
and transcriptional upregulation of toxin genes encoding Nga and streptolysin O.
The genetic relationships among GAS strains harboring emm89 and ∼20 additional emm types were
inferred based on ∼75,000 SNPs of the core genome
(111). The phylogeny shows that the emm89 isolates of
the three clades detailed above, and corresponding to
CC407 (ST101, ST407), cluster within the same major
lineage; ST142 isolates (double locus variants of ST407;
Fig. 5A) also cluster on that same deep branch. However, GAS of other emm types, plus emm89-ST380 isolates belonging to another CC (204), each cluster along
distinct lineages with deep branches (111). ST380 differs
from both ST101 and ST407 at all seven housekeeping
alleles, indicative of HGT of emm89 to a distant genetic
background.
The MLST data for emm89 strains captures two
different modalities of HGT involving emm: replacement of a nascent emm by a new emm type on the original genetic background (i.e., recipient-new clone pairs,
with two emm types and one ST) and lateral movement
of an emm type to a new genetic background (i.e., donor-new clone pairs, with one emm type and two STs)
(107). Within CC407 (recipient) there is evidence for the
former process, involving replacement of emm78 with
emm89 or vice versa (Fig. 5A). A possible donor of
emm89 to CC407 is emm89-ST380 (latter scenario);
alternatively, ST380 may have been the recipient of
emm89 from a CC407 donor. Comparisons of completely assembled genomes of possible donor-recipientnew clone pairings may aid in establishing the directionality of horizontal emm gene movements.
Based on the connections within CC407, the seven
housekeeping genes of MLST appear to recapitulate the
more expansive core genome sequence data reasonably
well. However, MLST fails to capture SNPs arising in
core virulence-related genes that may alter the trajectory
of GAS disease in a host population. What MLST may
be best tuned to, when combined with typing data on
emm, pilin genes, and/or sof, are HGT events wherein a
typing gene is present on distant STs/CCs or multiple
typing genes are recovered in association with the same
ST/CC (such as divergent Cpa-FctA in emm89-CC407;
Fig. 5B). For GAS, MLST relationships can provide an
intermediary link between short- and long-term evolution and may help delineate the genetic roots of the emer-
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FIGURE 5 Model for evolutionary descent (CC407). (A) goeBURST diagram of CC407,
which includes single representatives of 41 STs and is based on data from www.pubmlst.
org/spyogenes (105). Unless noted otherwise (orange shaded boxes), all isolates (n = 114)
are emm89 and were recovered from (i) the 1990s through 2010s, (ii) Europe or North
America, and (iii) URT infections or iGAS disease. For evolutionary analysis of emm89
(formerly PT4245 [250]) isolates based on the core genome sequence (31, 111), clade 1
strain MGAS11027 is ST407, whereas clade 2 and epidemic clade 3 strains (MGAS23530
and MGAS27061, respectively) are ST101; the epidemic emm89 strain H293 from the
United Kingdom is also ST101 (30). Note that ST407 corresponds to GAS with either
emm89 or emm78 (105). (B) Amino acid sequence identities among predicted FCT region
gene products of ST407 (MGAS11027) and ST101 (H293, MGAS23530) strains (all emm89)
via ClustalW alignments.
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gence of new strains that have unique repertoires of cell
surface antigens and their linked virulence functions.

EVOLUTION: MOLECULAR MECHANISMS
OF GENETIC CHANGE
Core genes of GAS contain a historical record of numerous homologous recombination events (111, 205–
208). Intraspeciﬁc gene exchange between GAS strains
most likely occurs during cocolonization of the URT or
coinfection of impetigo lesions with multiple strains
(209). GAS can grow as bioﬁlms or form microcolonies
during infection within both tissue niches (210, 211),
and the high bacterial density that is attained likely facilitates HGT. There is also ample evolutionary evidence
for gene exchange between GAS and other species, such
as SDSE (212–218).
A major unresolved puzzle of GAS biology is the
molecular mechanisms that govern HGT, leading to the
high rates of homologous recombination that is inferred
from its evolutionary history. In principle, nonspeciﬁc
packaging of chromosomal fragments into bacteriophage capsids could provide a vehicle for HGT of bacterial DNA (i.e., generalized transduction). In addition
to bacteriophage, GAS are also rich in integrative and
conjugative elements (91). The degree to which random
DNA fragments may slip through during the conjugative process remains unclear. A conserved RNA uracil
methyltransferase (rum) gene provides an integration
hotspot for both bacteriophage and integrative and conjugative elements in GAS, as well as other related species
(219). Natural transformation via high-frequency uptake of naked DNA has not been demonstrated for
GAS, although competence gene homologues are present
in the GAS genome and (very) low efﬁciency transformation is detectable in bioﬁlms (220–222). However,
GAS secrete numerous DNases that degrade extracellular DNA, which may render the transforming substance
unavailable for uptake by a competent cell.
A mutator phenotype that results in an increased
mutation rate has been characterized for GAS. This defect in DNA mismatch repair is controlled by excision
and reintegration of a streptococcal phage-like chromosomal island (SpyCI) at a site between the mutS and
mutL loci (223) and is present in the genomes of numerous GAS strains (50). SpyCI yields an ∼100-fold
increase in the rate of spontaneous mutation, to as high
as ∼10–7 to 10–8 mutations per generation. A possible
relationship between the presence of SpyCI and CCs
with a relatively low ratio of recombinational to mutational events remains to be explored.

EVOLUTION: LONG TERM
Core Housekeeping Genes
As previously stated, core genome-based phylogenies
of GAS of different emm types and/or CCs tend to yield
lineages with deep branches, indicative of large genetic
distances (50, 110, 111, 116). Whole-core genome
phylogenies depicted as SplitsTree graphs (neighbor-net
analysis) show recombination between GAS of different
emm types located deep within the network. Furthermore, there is no obvious clustering of the major lineages
in accordance with emm pattern grouping or by any
other recognized parameter.
Numerous methods have been used to assess the relative amount of recombination versus mutation that
contributes to genetic change in GAS, based on the seven
core housekeeping genes used in MLST (205–208). Together, the ﬁndings support the notion that GAS exhibit
relatively high levels of recombination which, at least
by some measures, is roughly comparable to the levels
observed for the pneumococcus.
Using MLST data, the relative amount of recombination versus mutation among the emm pattern-deﬁned
subgroups of GAS was examined (107, 224). Findings
based on several methodologies all point to the same
general trend, wherein the pattern A-C throat specialists
have the highest tendency to diversify by mutation, and
pattern D skin specialists and pattern E generalists have
a greater tendency to diversify by recombination. The
data on a larger role for mutation, relative to recombination, in genetic diversiﬁcation among the classical
throat strains is consistent with the molecular evolutionary analysis of emm subtypes (see “Epidemiology:
Evolution of Markers (emm)” above; Table 9) (107).
Differences among the emm pattern-deﬁned groups of
GAS in terms of their mechanisms for genetic change
underscore different dynamics in shaping their longterm population structures.
GAS strains may encounter ecological separation due
to their tissue site preferences for infection (throat versus
skin), geographic partitioning (temperate versus tropical) and temporal distances (winter versus summer).
Ecological barriers can give rise to allopatric speciation,
and therefore, signatures of early stages of speciation
within the GAS population may be evident. However,
analyses of housekeeping alleles provide strong support for highly ﬂuid HGT and homologous recombination of housekeeping genes among all three emm
pattern groupings (101, 128, 224). These ﬁndings extend to isolates known to be recovered from the URT
versus impetigo lesions, regardless of emm pattern group
(224).
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In summary, despite wide spatial-temporal distances
between many GAS strains, there is no clear evidence
for diminished opportunities for HGT of core housekeeping genes between organisms of the different emm
pattern groups. Numerous statistical measures all point
to a population genetic structure for the S. pyogenes
species that is highly nonclonal (205–208). Against a
background of highly random genetic change in core
housekeeping genes, loci that exhibit strong linkage with
emm pattern genotypes are reasonably good candidates
for playing a direct role in the adaptations leading to
throat versus skin infection (e.g., 50, 101).

Lateral Movement of emm
For the same global set of >500 GAS isolates used to
calculate Ka/Ks ratios within the emm type-speciﬁc region (see “Epidemiology: Evolution of Markers (emm)”
above), the number of HGT events as a function of emm
type was measured (107). Movement of emm to a distal
ST is quantiﬁed as recovery of an emm type in association with >1 ST differing by ≥5 of the 7 housekeeping
alleles; data show an average of 0.17, 0.60, and 0.75
lateral transfer events per emm type for the pattern A-C,
D, and E groups, respectively. This ﬁnding supports the
notion that for the classical throat strains, but less so for
skin strains or generalists, emm type is often a reasonably accurate marker for ST or CC (104, 107, 108). In
another measure of HGT and recombination, the number of emm types associated with emm type-variable
STs (i.e., STs recovered in association with >1 emm type)
was calculated; the number of emm type replacements
per ST was 0.12, 0.15, and 0.02 for pattern A-C, D, and
E isolates, respectively (107). Overall, there were three
times as many events captured for HGT of emm to a
distant ST (n = 63) than for replacement of emm on the
same ST (n = 21).
Taken together, these data shed light on GAS strain
competition surrounding the narrow time-space wherein
the donor, recipient, and newly emerged clone all coexist.
Strain competition can be mediated through host/herd
immunity (225) and perhaps via other host-pathogen
interactions as well. For the throat specialist strains,
competition appears to be most intense between strains
sharing the same emm type, because organisms of the
original ST that served as the (presumptive) emm donor
are rarely recovered. In contrast, for generalists, competition at the level of emm type appears to be considerably weaker, as evidenced by the frequent recovery of
the same emm type in association with multiple distant
ST backgrounds. How other cell surface antigens, such
as SOF and/or pili, might contribute to the competitive

sphere will require study of lateral movements of their
genes and alleles within the GAS population.

Full Complement of Epidemiological
Markers Considered
How do the host’s speciﬁc immune defenses perceive the
incoming antigenic repertoire present on the GAS cell
surface? Except during carriage, the Mga regulon that
upregulates the expression of emm and emm-like genes
and sof is typically active. The pilus T-antigens appear
to be expressed by >90% of the GAS population. The
expression/nonexpression of the hyaluronic acid capsule
can potentially mask/unmask some or all the GAS cell
surface proteins. Setting aside the variance in the transcriptional program, which can have a profound effect
on transmission and virulence (see “Evolution: Short
Term” below), the collection of epidemiological markers
provides a useful construct for deﬁning GAS “strains.”
Figure 6 summarizes the relative diversity or presence/
absence of each major epidemiological marker in accordance with the emm pattern-deﬁned groupings of throat
specialists, skin specialists, and generalists. Importantly,
emm type is rarely recovered in association with multiple
emm pattern groupings (Table 2), thereby allowing
reasonably valid inferences to be drawn. The patternand cluster-deﬁned emm subtype alleles reveal stark differences between the throat specialist, skin specialist, and
generalist groupings regarding diversiﬁcation (Table 9).
Major distinctions also lie in the relative distributions of
the sof locus (Table 4), emm-like genes (see Fig. 2B), and
FCT region forms (Fig. 3) (82).
Do highly diverse emm subtypes compensate for the
dearth of emm-like genes and sof among the throat
specialists—and vice versa for the generalists? The diversity among mrp and enn alleles is modest, but they
too have undergone intraspecies HGT (226); selection
may be tied to functional binding attributes of the Mrp
or Enn proteins (e.g., IgA, IgG) (63, 227–230). The sof
gene also undergoes rather extensive intraspecies HGT
(80); however, sof gene movement is nonrandom in
that it is largely restricted to the emm pattern E generalists (Table 4). Yet the relationships between individual emm types and sof types are highly varied, with
many unique combinations arising via HGT to distant
genetic backgrounds (35).
Among the throat specialist group is a wide variety
of FCT region forms (Fig. 6) (82). The FCT-1 region is
the most prevalent form among representative pattern
A-C organisms of unique emm types; FCT-1 is characterized by an AP1 adhesin (FctX) and major BP (Tee)
that are markedly divergent from the highly variable
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FIGURE 6 Trends in the distribution of epidemiological markers. An overview of the
diversity and/or occurrence of epidemiological marker genes among three clinicoepidemiologic phenotype groupings of GAS. The relative distribution of FCT region forms
is in accordance with one representative isolate for 94 unique emm types, as reported in
reference 82; however, given the extensive HGT of emm and/or FCT genes to distant
genetic backgrounds, the present analysis of the FCT region distribution may be far from
complete.

Cpa and FctA pilins of FCT-3 and FCT-4 (82, 92). Not
shown in Fig. 6 is FCT-2, which is (almost) exclusive to
the highly prevalent emm1 organisms; the AP1 and BP
pilins of FCT-2 are akin to a distant lineage of Cpa and
FctA, respectively (82). Thus, the unusually high success
(i.e., ﬁtness) of emm1 strains may be due, in part, to its
antigenically unique pilus structure. Overall, the absence
of sof and emm-like genes among the pattern A-C strain
grouping may be compensated for by the antigenic and
structural diversity among its pili.
The skin specialist group appears to be the most homogeneous regarding epidemiological marker loci content, largely lacking sof but having both mrp and enn,
and an FCT-3 region skewed heavily toward T3/13/
B3264 (Table 5); this genotype is coupled to the lowest
diversity among emm subtypes (Table 9). Also, the skin
specialist group is dominated by emm cluster D4, encoding the plasminogen-binding M protein (51, 65).
However, past lateral movement of emm type to distant
genetic backgrounds is rather abundant among the skin
specialists and is ∼2-fold greater than that of emm type
replacement on the same ST (107) (see “Lateral Movement of emm” above); there is also ample HGT of
housekeeping alleles. Conceivably, the emm pattern D
skin specialists represent a more recent subpopulation of
GAS (i.e., younger) that has less diversity within any one
gene, but the genes themselves are highly recombinatorial. Alternatively, the cell surface protein repertoire of
skin specialists may be subject to less intense pressures
for diversifying selection, perhaps due to its microenvironment and/or the host immune response at the skin.

The relative lack of pattern D and E emm types recovered in association with FCT-1 or FCT-2 regions
may be indicative of functional constraints that would
otherwise lower ﬁtness, such as inadvertent adherence
to a suboptimal tissue via speciﬁc host receptors. As
a group, the emm pattern E generalists display all the
emm region epidemiological markers and tend to have
either the large FCT-4 region or FCT-5 (Fig. 6), both of
which harbor the prtF1 gene that encodes a ﬁbronectinbinding protein (Fig. 3). Pattern E strains are also
characterized by relatively high levels of recombination,
involving both emm and the seven core housekeeping genes of MLST (50, 231, 232). Conceivably, within
the generalist grouping are discrete throat or skin specialist strains whose phenotype is masked by the organizational framework (i.e., emm pattern group) that is
imposed.
Historically GAS “strains” have been deﬁned (primarily) by M serotype and secondarily by T and/or
SOF serotype in combination with M type. Over the
past 2 decades, emm typing has largely replaced GAS
serotyping. The multitude of combinations of emm type
and ST underscores the HGT of emm type, which is also
consistent with the diverse array of M, T, and SOF serotype combinations observed. Even within a CC, STs
are found in association with multiple emm types and/
or divergent pilin genes (e.g., Fig. 5). Therein lies a conundrum for studying the population biology of GAS:
How does one best deﬁne “strain?” This may or should
be one of the next new challenges to be addressed by the
GAS ﬁeld.

ASMscience.org/MicrobiolSpectrum

23
Downloaded from www.asmscience.org by
IP: 64.118.223.196
On: Wed, 07 Nov 2018 01:48:52

Bessen et al.

EVOLUTION: SHORT-TERM
The monophyletic grouping of GAS strains in accordance with emm type and/or MLST-deﬁned CC readily
allows for inference of ancestral-descendent pairs within
a branch, especially when coupled to epidemiological
collections of strains with known dates of recovery.
Whole-genome sequences of hundreds or thousands of
GAS isolates sharing the same emm type and collected
over a narrow spatial-temporal distance have captured
epidemic waves of clones that are distinct from presumptive ancestral clones (24, 30, 111, 113–115, 233).
An important ﬁnding is that within an emm type (speciﬁcally, emm1 and emm3), iGAS isolates arise from all
major lineages occupied by URT isolates and are genetically similar to the circulating pharyngitis strains
from which they evolved (114, 234).
Comparative genomics of GAS recovered within a
narrow spatial-temporal distance, and in association
with a deﬁned bacteria-host ecology (i.e., pharyngitis,
asymptomatic carriage, and/or iGAS disease), have revealed high levels of diversifying selection at certain
loci, particularly those involved in regulating the phenotypic expression of virulence factors (24, 30, 44,
111, 113–115, 233–240). Affected loci include hasABC
(hyaluronic acid capsule biosynthesis), covRS (twocomponent system that acts as a global regulator), rgg/
ropB (standalone response regulator), mga (response
regulator and activator of emm transcription), lia (sensor kinase), and nga-slo (exotoxins). There are some
recurrent themes, wherein downregulation of emm enhances URT carriage, downregulation of speB enhances
iGAS disease, and upregulation of nga-slo enhances
URT transmission. The contribution of capsule to GAS
ecology seems more complex, and perhaps it is GAS
strain dependent. In fact, in general terms, all mutations
that alter ﬁtness are context dependent and, accordingly,
may be strain dependent. In addition to SNPs in critical
virulence loci, GAS genomes are profoundly shaped by
mobile genetic elements (which are often not included as
part of the core genome); bacteriophage and integrative
and conjugative elements can harbor critical virulence
genes as well (e.g., 114).

EVOLUTION (OR NOT):
RESURGENCE OF SCARLET FEVER
Scarlet fever (SF) was a dreaded GAS disease through the
early 1900s; it manifests as a URT infection coupled to a
pathognomonic scarlatina rash triggered by the action of
erythrogenic toxin, which was subsequently characterized as a T-lymphocyte superantigen. The occurrence of

SF in the United States and Europe declined mid-century
and was largely sporadic in recent decades. However, in
2011 there was an alarming increase in the number of
reported cases of SF in Hong Kong and in China soon
thereafter (241–243). This upsurge was largely attributed to emm12 GAS organisms that were resistant to
macrolides and tetracycline. Comparative genome sequence analysis with other emm12 strains revealed a
novel prophage harboring the superantigen genes speC
and ssa (113, 244). However, the Hong Kong SF outbreak was multiclonal in origin.
A resurgence of SF cases also occurred in the United
Kingdom, beginning in ∼2013 (245). Comparative genomics failed to reveal a single clone or a single gene
(e.g., a superantigen gene on a mobile genetic element)
associated with those disease cases. As in Asia, the increase in SF incidence was associated with multiple
lineages of GAS (246, 247).
Taken together, the recent upsurge in SF appears
to be multifactorial and likely includes host-related factors. Numerous GAS lineages are responsible for SF,
although resistance to antibiotics may have fueled the
spread of some clones. Possible shifts in the content of
superantigen genes may collectively have had an effect.
The two cohorts—children in Asia and Europe and
largely nonrural—possibly had a history of past exposure to a similar set of prevalent emm types and strains
(131), and their herd immunity may be similar despite
the geographic distance. Conceivably, an unknown
copathogen may affect host susceptibility to SF and development of the scarlatina rash. Heightened clinician
awareness and better reporting and surveillance, and/or
changes in clinical practice, can also contribute to a
higher disease incidence. The mysterious underpinnings
of the recent upsurge in SF cases in Asia and Europe
underscore the contributory role of factors other than
genetic changes in GAS in shaping the epidemiology of
GAS disease.

EVOLUTION AND POPULATION DYNAMICS
A central problem concerning GAS is the difﬁculty in
connecting the evolutionary histories of different emm
type-deﬁned strains. There are large genetic gaps between extant organisms—but also rampant gene ﬂow.
So, what became of the evolutionary intermediates?
Was there an extended series of population bottlenecks
whereby new clones outcompeted their progenitors?
And perhaps each successful new clone bore a new emm
subtype plus changes in other genes, until a very unique
and highly ﬁt organism with a far more divergent emm
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type emerged and gained a strong foothold in the human
host population. Perhaps the genetic intermediates went
extinct due to low ﬁtness in the context of shifting hostenvironmental conditions, or perhaps they remain extant, lurking in low numbers in a semiquiescent state and
have yet to be sampled.
When did GAS emerge as a human pathogen? Was the
GAS progenitor a human commensal? Or was the progenitor an animal pathogen that has yet to be recovered
via sampling? Did the new GAS pathogen acquire key
genes from a trading partner as a pivotal step in its
emergence? What are the genotypes that confer adaptation of GAS to the primary ecological niches of the throat
and skin? Are GAS commensals at heart, and should one
view their ecology primarily through that lens?
What was the structure of the human population at
the time GAS emerged as a human pathogen—highly
migratory with intermingling or isolated tribes? What
is the minimum host population size necessary to sustain GAS transmission? What becomes of a GAS strain
if/when it runs out of susceptible hosts? Does the organism persist in an altered carrier state? Why do there
exist ∼243 emm types? And why are there even far
larger numbers of unique combinations of M, SOF, and
T antigens? Is the number of unique combinations of cell
surface proteins related to characteristics of the human
host population? If so, how?
What are the selective pressures shaping the GAS
population of today? Is the ability to cause a clinically
inapparent infection a more recent adaptation, driven
by social behavior in the form of seeking antibiotics
when ill, thereby giving the stealth invader a survival
advantage? Why did SF recently re-emerge in Asia and
the United Kingdom? Why did acute rheumatic fever
undergo a renaissance in the United States during the
1980s? How might a future vaccine alter its evolutionary
trajectory? A better understanding of the ecology and
evolution of GAS, and its population genetic structure,
may ultimately lead to interventions that limit its impact
on human health.
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